Long BIIB

NASDAQ:BIIB1D

Biogen Inc.NASDAQ

Description

⋅ 8 janv. 2021 22:45

BIIB Daily Chart , Not a High Quality Trade!

Trade fermée: cible de profit atteinte

⋅ 15 janv. 2021 21:26

Boooom

Trend Analysis

Commentaires

Soartrader1

⋅ 9 janv. 2021 05:28

It will be a high quality trade if BIIB reruns their clinical trial on Aducanumab @10mg/kg, factors out the APO-E carriers and can show statistical improvement in cognition without adverse side effects. Will know by March if they hold an ace

Plus